BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36385393)

  • 1. A sensitivity analysis approach for the causal hazard ratio in randomized and observational studies.
    Axelrod R; Nevo D
    Biometrics; 2023 Sep; 79(3):2743-2756. PubMed ID: 36385393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The built-in selection bias of hazard ratios formalized using structural causal models.
    Post RAJ; van den Heuvel ER; Putter H
    Lifetime Data Anal; 2024 Apr; 30(2):404-438. PubMed ID: 38358572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal Inference in Studying the Long-Term Health Effects of Disasters: Challenges and Potential Solutions.
    Shiba K; Kawahara T; Aida J; Kondo K; Kondo N; James P; Arcaya M; Kawachi I
    Am J Epidemiol; 2021 Sep; 190(9):1867-1881. PubMed ID: 33728430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Cox analysis of a randomized survival study yield a causal treatment effect?
    Aalen OO; Cook RJ; Røysland K
    Lifetime Data Anal; 2015 Oct; 21(4):579-93. PubMed ID: 26100005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causal inference in survival analysis using pseudo-observations.
    Andersen PK; Syriopoulou E; Parner ET
    Stat Med; 2017 Jul; 36(17):2669-2681. PubMed ID: 28384840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causal Methods for Observational Research: A Primer.
    Almasi-Hashiani A; Nedjat S; Mansournia MA
    Arch Iran Med; 2018 Apr; 21(4):164-169. PubMed ID: 29693407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies.
    Schuler MS; Rose S
    Am J Epidemiol; 2017 Jan; 185(1):65-73. PubMed ID: 27941068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clarifying selection bias in cluster randomized trials.
    Li F; Tian Z; Bobb J; Papadogeorgou G; Li F
    Clin Trials; 2022 Feb; 19(1):33-41. PubMed ID: 34894795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. causalCmprsk: An R package for nonparametric and Cox-based estimation of average treatment effects in competing risks data.
    Vakulenko-Lagun B; Magdamo C; Charpignon ML; Zheng B; Albers MW; Das S
    Comput Methods Programs Biomed; 2023 Dec; 242():107819. PubMed ID: 37774426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doubly-robust methods for differences in restricted mean lifetimes using pseudo-observations.
    Choi S; Choi T; Lee HY; Han SW; Bandyopadhyay D
    Pharm Stat; 2022 Nov; 21(6):1185-1198. PubMed ID: 35524651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxed covariate overlap and margin-based causal effect estimation.
    Ghosh D
    Stat Med; 2018 Dec; 37(28):4252-4265. PubMed ID: 30168168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing causal effects in observational survival data using propensity score matching design.
    Lu B; Cai D; Tong X
    Stat Med; 2018 May; 37(11):1846-1858. PubMed ID: 29399833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes.
    Austin PC; Stuart EA
    Stat Methods Med Res; 2017 Aug; 26(4):1654-1670. PubMed ID: 25934643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaplan-Meier curves for survivor causal effects with time-to-event outcomes.
    Chiba Y
    Clin Trials; 2013 Aug; 10(4):515-21. PubMed ID: 23610455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causal proportional hazards models and time-constant exposure in randomized clinical trials.
    Loeys T; Goetghebeur E; Vandebosch A
    Lifetime Data Anal; 2005 Dec; 11(4):435-49. PubMed ID: 16328570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of treatment effect under non-proportional hazards and conditionally independent censoring.
    Boyd AP; Kittelson JM; Gillen DL
    Stat Med; 2012 Dec; 31(28):3504-15. PubMed ID: 22763957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How serious is bias in effect estimation in randomised trials with survival data given risk heterogeneity and informative censoring?
    McNamee R
    Stat Med; 2017 Sep; 36(21):3315-3333. PubMed ID: 28621000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.
    Latimer NR; Abrams KR; Siebert U
    BMC Med Res Methodol; 2019 Mar; 19(1):69. PubMed ID: 30935369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.